Stock Quotes & Company News | Reuters.com
Edition:
United States

People: Transition Therapeutics Inc (TTH.TO)

TTH.TO on Toronto Stock Exchange

1.88CAD
30 Jun 2016
Change (% chg)

$0.99 (+111.24%)
Prev Close
$0.89
Open
$1.79
Day's High
$1.93
Day's Low
$1.79
Volume
412,433
Avg. Vol
22,612
52-wk High
$3.87
52-wk Low
$0.89

Henley, Christopher 

Mr. Christopher Henley is Independent Director of Transition Therapeutics Inc. Mr. Henley is founder and President of Henley Capital Corporation, a boutique investment dealer specializing in financial, mergers and acquisitions and advisory services to companies covering the full spectrum of high technology. Prior to this, Mr. Henley was the head of investment banking in Toronto and ran the High Technology and Communications practice at Canada's largest independent employee-owned investment dealer. He has been an investment banker for over 20 years and sits on a number of public and private boards of directors.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Tony Cruz

424,876

Carl Damiani

199,228

Nicole Rusaw

316,054

Bruce Connop

287,182

Aleksandra Pastrak

407,711

Louis Alexopoulos

--
As Of  29 Jun 2013